Related Experiment Video
Updated: Sep 19, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Organic AIE Nanoradiosensitizer Potentiates X-Ray Triggered Continuous Reactive Oxygen Species Generation for Potent
Qingyong Xu1, Minmin Zhang2, Qinqin Huang3
1Department of Breast Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, P. R. China.
Abstract:
Organic radiosensitizers (ORSs), with structural versatility, hold promise for sensitizing radiotherapy (RT) by interacting with X-ray photons to generate reactive oxygen species (ROS). They often consist of low-Z elements that have inherently low X-ray deposition capability. However, current ORSs suffer from short circulation half-lives and low tumor retention, contradicting their requirements for sustained ROS generation upon RT in tumor sites. Herein, a glutathione-responsive system is prepared, loaded with aggregation-induced emission molecules (TPEPy-I) and Ferriprotoporphyrin IX chloride (Hemin), to act as an ORS (named THN) for X-ray triggered sustained ROS generation for efficient antitumor immunotherapy. In detail, THN effectively deposited X-ray photons, which interact with water molecules to generate abundant ROS under external radiation. Subsequently, THN-mediated radiosensitization stimulated tumor cells to produce hydrogen peroxide (H2O2) by upregulating NOX4 protein, promoting the chemodynamic process of Hemin reacting with H2O2 to continuously produce hydroxyl radicals. The double-promoting ROS generation of THN induced massive immunogenic cancer cell death and polarized M2 macrophages into the M1 phenotype for enhanced antitumor immunotherapy. Experiments revealed that THN-sensitized RT inhibited tumor recurrence and increased memory T-cell proportion for long-term antitumor immunity. The developed ORS has great clinical potential as both a radiosensitizer and a post-RT immunomodulatory agent.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Isotopes and Radioisotopes
An isotope containing...

